Edition:
United Kingdom

Avadel Pharmaceuticals PLC (AVDL.OQ)

AVDL.OQ on NASDAQ Stock Exchange Global Market

2.54USD
18 Jan 2019
Change (% chg)

$-0.11 (-4.15%)
Prev Close
$2.65
Open
$2.68
Day's High
$2.68
Day's Low
$2.44
Volume
8,802
Avg. Vol
44,581
52-wk High
$11.91
52-wk Low
$1.69

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 19.83 -0.427
Jun '18 29.23 -0.094
Mar '18 33.29 -0.317
FY 2017 Dec '17 34.75 -0.299
Sep '17 39.67 0.524
Jun '17 46.31 0.681
Mar '17 52.51 0.605
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-19 2 68.92 74.15 63.69 147.72
Earnings (per share)
Quarter Ending Mar-19 1 -0.44 -0.44 -0.44 --
Quarter Ending Jun-19 1 -0.40 -0.40 -0.40 --
Year Ending Dec-19 1 -1.54 -1.54 -1.54 -0.39
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 12.12 69.71 33.71
P/E High - Last 5 Yrs. 12.72 148.01 49.93
P/E Low - Last 5 Yrs. 12.72 47.79 24.27
Beta 1.45 1.08 0.90
Price to Sales (TTM) 2.56 49.51 6.28
Price to Book (MRQ) 5.80 10.16 5.27
Price to Tangible Book (MRQ) 12.18 13.82 6.79
Price to Cash Flow (TTM) 9.27 52.80 24.84
% Owned Institutions 73.99 3.75 1.69

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.40
Dividend Yield - 5 Year Avg -- 0.09 1.42
Dividend 5 Year Growth Rate -- 0.79 4.83
Payout Ratio(TTM) 0.00 7.04 41.08

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 19.18 130.03 9.72
Sales (TTM) vs TTM 1 Yr. Ago 4.21 47.85 5.87
Sales - 5 Yr. Growth Rate 35.74 22.76 11.20
EPS (MRQ) vs Qtr. 1 Yr. Ago 240.69 75.87 47.26
EPS (TTM) vs TTM 1 Yr. Ago 1,446.46 -- --
EPS - 5 Yr. Growth Rate -- 12.03 10.82
Capital Spending - 5 Yr. Growth Rate -8.79 9.24 15.18

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 2.24 2.18 2.26
Current Ratio (MRQ) 2.30 3.43 3.08
LT Debt to Equity (MRQ) 113.96 18.73 11.38
Total Debt to Equity (MRQ) 114.34 31.43 16.13
Interest Coverage (TTM) 18.92 -43.27 29.51

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 92.01 56.29 53.78
Gross Margin - 5 Yr. Avg. 91.71 60.55 52.17
EBITD Margin (TTM) 44.52 -- --
EBITD - 5 Yr. Avg 32.50 -110.23 12.87
Operating Margin (TTM) 39.28 -184.42 6.20
Operating Margin - 5 Yr. Avg. -26.14 -126.67 8.31
Pre-Tax Margin (TTM) 41.54 -175.20 7.17
Pre-Tax Margin - 5 Yr. Avg. -25.54 -132.83 8.61
Net Profit Margin (TTM) 22.75 -181.93 3.30
Net Profit Margin - 5 Yr. Avg. -40.07 -137.23 4.88
Effective Tax Rate (TTM) 45.25 21.48 22.88
Effective Tax Rate - 5 Yr. Avg. -- 15.57 23.39

Efficiency

  Company industry sector
Revenue/Employee (TTM) 1,054,485 7,650,695 844,239,566
Net Income/Employee (TTM) 239,861 652,572 100,064,145
Receivable Turnover (TTM) 12.09 6.25 5.72
Inventory Turnover (TTM) 2.96 1.89 3.48
Asset Turnover (TTM) 0.68 0.32 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 15.55 6.45 11.08
Return on Assets - 5 Yr. Avg. -17.97 5.52 12.21
Return on Investment (TTM) 21.87 8.99 14.48
Return on Investment - 5 Yr. Avg. -24.65 6.85 15.88
Return on Equity (TTM) 61.57 10.13 15.99
Return on Equity - 5 Yr. Avg. -92.89 8.39 17.00
  1 Year 3 Year 5 Year
Sales % -13.16 230.05 35.74
EPS (TTM) % -204.24 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Avadel Pharmaceuticals PLC

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 23.33 19.08 99 99
13 Week 2.49 -2.50 99 95
26 Week 10.34 1.95 99 98
52 Week -11.83 -25.27 70 72
YTD 6.83 -6.18 94 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 58.73%
# of Holders: 83
Total Shares Held: 21,736,980
3 Mo. Net Change: 1,079,199
# New Positions: 0
# Closed Positions: 1
# Increased Positions: 2
# Reduced Positions: 4
# Net Buyers: -2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.